The grant would have used artificial intelligence to shorten drug development and provide affordable drugs, vaccines and diagnostics.

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Biotechnology company Regeneron Pharmaceuticals ... notably spanning from a 2023 data breach - along with questions around what new ownership could mean for users' data. RELATED: 23andMe ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

HOLLY SPRINGS, N.C. -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million ...

and add new ones where warranted, to ensure that China cannot obtain bulk and sensitive biological data from the United States; 4.3a Congress must establish Centers for Biotechnology within the ...

Bharat Biotech’s oral cholera vaccine, Hillchol, aims to ease a critical global shortfall, with the world currently lacking ...

Cvictus recently received a $1.7 million grant from the Bill & Melinda Gates Foundation to scale its technology.

Now is the time for the biotechnology sector to ask for big changes to the FDA, NIH, reimbursement, intellectual property and tax rules, writes former Trump administration official Joe Grogan.